Growth Metrics

Eli Lilly (LLY) Gross Profit (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.90%
Dec 31, 2025 9.10%
Sep 30, 2025 11.31%
Jun 30, 2025 24.81%
Mar 31, 2025 -5.62%
Dec 31, 2024 20.08%
Sep 30, 2024 1.49%
Jun 30, 2024 28.73%
Mar 31, 2024 -6.23%
Dec 31, 2023 -0.96%
Sep 30, 2023 17.43%
Jun 30, 2023 21.96%
Mar 31, 2023 -7.31%
Dec 31, 2022 7.30%
Sep 30, 2022 6.03%
Jun 30, 2022 -11.86%
Mar 31, 2022 -3.56%
Dec 31, 2021 11.38%
Sep 30, 2021 11.60%
Jun 30, 2021 -2.84%
Mar 31, 2021 -13.87%
Dec 31, 2020 29.59%
Sep 30, 2020 3.20%
Jun 30, 2020 -7.91%
Mar 31, 2020 -3.86%
Dec 31, 2019 12.32%
Sep 30, 2019 -4.66%
Jun 30, 2019 14.12%
Mar 31, 2019 -12.29%
Dec 31, 2018 8.51%
Sep 30, 2018 -4.52%
Jun 30, 2018 14.52%
Mar 31, 2018 -15.87%
Dec 31, 2017 10.91%
Sep 30, 2017 -4.25%
Jun 30, 2017 9.59%
Mar 31, 2017 -9.64%
Dec 31, 2016 13.29%
Sep 30, 2016 -3.78%
Jun 30, 2016 11.23%
Mar 31, 2016 -11.15%
Dec 31, 2015 7.08%
Sep 30, 2015 -1.00%
Jun 30, 2015 8.93%
Mar 31, 2015 -10.76%
Dec 31, 2014 7.19%
Sep 30, 2014 -3.67%
Jun 30, 2014 8.25%
Mar 31, 2014 -21.75%
Dec 31, 2013 -3.33%
Sep 30, 2013 -3.99%
Jun 30, 2013 7.22%
Mar 31, 2013 -5.63%
Dec 31, 2012 11.07%
Sep 30, 2012 -4.81%
Jun 30, 2012 1.13%
Mar 31, 2012 -6.79%
Dec 31, 2011 -1.77%
Sep 30, 2011 -4.28%
Jun 30, 2011 7.85%
Mar 31, 2011 -5.97%
Dec 31, 2010 10.13%
Sep 30, 2010 -1.45%
Jun 30, 2010 4.64%
Mar 31, 2010 -3.11%
Dec 31, 2009 3.91%
Sep 30, 2009 -0.27%
Jun 30, 2009 2.71%